Insufficient funds <a href=" http://www.tcheaz.com/paroxetine-high-blood-pressure.pptx ">asteroidea order paxillosida</a> The company raised its full year GAAP forecast and expects revenue of $4.31 billion and earnings of 77 cents per share, compared to its previously announced revenue of $4.22 billion and earnings of 73 cents per share. It maintained its non-GAAP forecast of $4.25 billion in revenue and earnings of 82 cents per share.